论文部分内容阅读
Non-progressive HIV-1-infected therapy individuals, who have been infected for 20+ years, may harbor clues to biopharmaceuticals and have the potential to explain underlying mechanisms of nonprogressive HIV disease. Viral evolutionary processes play a significant role in disease progression, and they can also serve a guiding tool to the discovery of natural anti-HIV agents from such rare individuals who comprise 0.8% of total HIV-infected population.